Sorted by Relevance | Sort by Date
Search Results for Linden+Lab
Second life: Hookup for virtual pedophilia?
Update, 5/11: In the wake of this controversy, Linden Labs has purged Second Life of those responsible for the behavior described below. Kudos to them. More than six million people worldwide have found a way to live a second, more fulfilling life ...
Interview with the head of Xerox's (XRX) Webster research lab
In Corporate America there are few research labs left. Basically, Wall Street tends to focus on short-term result. Why then invest lots of money on something that may take years to hit critical mass?
Well, in the case of Xerox (NYSE: XRX), the ...
Earnings preview: Abbott Labs Q3 acquisitions to pay off?
Abbott Laboratories (NYSE: ABT), the broad-based health care company that produces both Humira and Similac, is scheduled to discuss its third quarter 2009 financial results in a conference call Wednesday at 9:00 AM ET. You can catch the live webcast ...
Abbott Labs to pay J&J $1.67 billion from patent lawsuit
Yesterday, pharmaceutical giant Johnson & Johnson (JNJ) said that its patent infringement lawsuit against Abbott Labs (ABT) was successful, with Abbott ordered to pay $1.67 billion because its best-selling drug, Humira, too closely resembles ...
Another issue for Microsoft's Vista: a merger of open source foundations
With Microsoft's (NASDAQ: MSFT) Vista launch, the world of operating systems is looking very different. A big problem: there is competition from open source approaches, especially Linux.
Basically, open source is a way to develop software that ...
Option update 11-27-07: MYL, FRX volatility up as shares dip
Mylan Lab (NYSE: MYL), a leading pharmaceutical company, closed at $13.53. Goldman Sachs says, "Upgrading to Buy with $19 price target, we see a bottom in shares." MYL overall option implied volatility of 46 is above its 26-week average of 39 ...
Hottest Products of 2007: Second Life offers virtual fulfillment
This post is part of our Hottest Products of 2007 feature. Check out our other Hottest Products of 2007 posts and let us know which product you think is the greatest thing since sliced bread.
If you find life a little boring, stifling and basically ...
Analyst upgrades, downgrades and initiations: AZN, AZO, BBBY, CAH, CPN, LLL, LTD ...
Analyst upgrades:
FBR Capital upgraded AutoZone (NYSE: AZO) to Market Perform from Underperform on valuation following the company's Q4 results but lowered its target on shares to $134 from $137.
Citigroup upgraded Calpine (NYSE: CPN) to ...
Analyst upgrades, downgrades and initiations: AMZN, BA, BAC, F, LUV, LYG T, WEN ...
Analyst upgrades:
RBC Capital upgraded Bank of America (NYSE: BAC) to Outperform from Sector Perform and said the company has attractive franchise value and earnings power, and is nearing the start of a credit driven earnings recovery. The firm ...
Symantec's (SYMC) snags MessageLabs for $695 million
With virtually no IPOs, tech companies have little choice but to sell out. Just take a look at MessageLabs, which has agreed to a $695 million deal from Symantec (NASDAQ: SYMC).
The main focus of MessageLabs is on securing email and messaging. OK, ...
Coke (KO) invests in India, despite opposition
Coca-Cola (NYSE: KO) announced that it plans to drop a quarter of a billion dollars on expansion of its business in India. The investment will be spread throughout the supply chain, including a retail university and a new testing lab. The company ...
Analyst upgrades: SNY, LIFC, MYL, PNRA and NHY
MOST NOTEWORTHY: Sanofi-Aventis, Lifecell, Mylan Labs, Panera Bread and Norsk Hydro were today's noteworthy upgrades:
Societe Generale upgraded shares of Sanofi-Aventis (NYSE: SNY) to Buy from Hold as they believe pipeline maturation over the ...
Analyst initiations: GPRO, MNST, LH and DGX
MOST NOTEWORTHY: Gen-Probe, Monster Worldwide, LabCorp and Quest Diagnostics were today's noteworthy initiations:
Deutsche Bank initiated shares of Gen-Probe (NASDAQ: GPRO) with a Buy rating and $78 target and expects the company's broad ...
Analyst initiations: Och-Ziff Capital, FactSet, Forest Labs, optical component makers
MOST NOTEWORTHY: Och-Ziff Capital, FactSet, Forest Labs and certain optical component maker and provider stocks were today's noteworthy initiations.
Och Ziff Capital Management Group (NYSE: OZM) was initiated with an Overweight by JP Morgan, ...
Analyst initiations: PRSP, MVO and BRLI
MOST NOTEWORTHY: Properity Bancshares, MV Oil Trust and Bio-Reference Lab were today's noteworthy initiations:
B. Riley initiated Prosperity Bancshares (NASDAQ:PRSP) with a Buy rating and $32 target. The firm thinks the company's lower risk ...
Entrepreneur's Journal: Want to get a piece of the Buffett/Goldman honeypot?
The week in preview: No turkey earnings from Tyson, Hormel, Cracker Barrel ...
Comfort Zone Investing: Intel is saying something ... can you hear it?
